Association of plasma levels of Protein S with disease severity in multiple sclerosis

Gerry Zm Ma1, Lauren L Giuffrida1, Melissa M Gresle2

  • 1Multiple Sclerosis Division, The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Australia.

Abstract

Insights

Plasma levels of Protein S (PROS) are decreased in multiple sclerosis (MS) patients. Lower PROS levels correlate with increased MS disease severity, suggesting PROS as a potential biomarker.

Area of Science:

  • Neuroimmunology
  • Biomarker Discovery

Background:

  • The TAM family of receptor tyrosine kinases (TYRO3, AXL, MERTK) are crucial in innate immunity and central nervous system demyelination.
  • Protein S (PROS), a ligand for TAM receptors, influences innate immune cell responses.

Purpose of the Study:

  • To investigate alterations in plasma PROS levels in multiple sclerosis (MS) patients.
  • To determine if changes in PROS levels correlate with MS disease severity.

Main Methods:

  • Plasma levels of total and free PROS were quantified using enzyme-linked immunosorbent assay (ELISA).
  • Two cohorts were utilized: a discovery cohort (65 MS, 14 control) and a replication cohort (29 MS, 29 control).
  • The Multiple Sclerosis Severity Score (MSSS) assessed disease severity in relation to PROS levels.

Main Results:

  • Total PROS levels were significantly decreased in MS patients compared to controls.
  • Female MS patients exhibited reduced levels of both total and free PROS.
  • Very low plasma free PROS levels were associated with higher MSSS, indicating greater disease severity.

Conclusions:

  • Plasma PROS levels are altered in multiple sclerosis.
  • PROS may serve as a potential biomarker for assessing MS disease severity.